Provided by Tiger Trade Technology Pte. Ltd.

Liberty All-Star Equity

5.87
-0.0300-0.51%
Pre-market: 5.900.0267+0.45%07:04 EDT
Volume:1.74M
Turnover:10.22M
Market Cap:1.81B
PE:24.47
High:5.90
Open:5.88
Low:5.86
Close:5.90
52wk High:6.56
52wk Low:5.40
Shares:308.22M
Float Shares:308.22M
Volume Ratio:1.15
T/O Rate:0.56%
Dividend:0.67
Dividend Rate:11.41%
EPS(TTM):0.2399
EPS(LYR):0.5568
ROE:3.61%
ROA:0.33%
PB:0.89
PE(LYR):10.54

Loading ...

SoundThinking Announces First Quarter 2026 Financial Results Date and Conference Call

GlobeNewswire
·
Apr 24

Lifetime Brands Announces First Quarter 2026 Financial Results Release Date

GlobeNewswire
·
Apr 23

Goodman Group Announces Cash Tender Offer

GlobeNewswire
·
Apr 21

Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire
·
Apr 21

Dunlop Aircraft Tyres Appoints Mick Wallwork as Chief Executive Officer

prnewswire
·
Apr 20

Kailera Therapeutics Announces Pricing of Initial Public Offering

GlobeNewswire
·
Apr 17

Press Release: Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock

Dow Jones
·
Apr 17

Press Release: Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership

Dow Jones
·
Apr 15

Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes

GlobeNewswire
·
Apr 15

Allogene Therapeutics Announces Pricing of Public Offering of Common Stock

GlobeNewswire
·
Apr 15

Fortune expands Asia leadership with new Editorial Directors and Brand Studio head

prnewswire
·
Apr 15

BRIEF-Liberty All-Star® Equity Fund March 2026 Monthly Update

Reuters
·
Apr 15

Liberty All-Star Equity Fund March NAV falls 6.4%

Reuters
·
Apr 15

Liberty All-Star Equity Fund - Reports Total Net Assets of $1,878.7 Mln at March 2026 Month-End

THOMSON REUTERS
·
Apr 15

Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock

GlobeNewswire
·
Apr 14

Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC

prnewswire
·
Apr 13

IRIS Optronics Leads the New Era of ChLCD e-Paper

prnewswire
·
Apr 13

Unichem’s U.S. Unit Voluntarily Recalls Buspirone Tablets on Quality Deviation

TIPRANKS
·
Apr 12

American Rare Earths Defines Wyoming-Led Pilot Plant Pathway to Accelerate Pre-Production Rare Earth Oxide

GlobeNewswire
·
Apr 09

InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor

GlobeNewswire
·
Apr 09